The company and its Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
The term of the 5th Board of Directors of Boji Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") is about to expire. In accordance with the "Company Law," the "Shenzhen Stock Exchange GEM Stock Listing Rules," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guide No. 2 - Normative Operation of GEM Listed Companies," and the "Articles of Association," the Company has conducted the election of the Board of Directors according to the relevant procedures. The relevant situation is hereby announced as follows:
I. Appointment of the New Board of Directors
On July 15, 2026, the Company held the 22nd meeting of the 5th Board of Directors, which reviewed and approved the "Proposal on the Election of the Board of Directors and Nomination of Non-Independent Director Candidates for the 6th Board of Directors" and the "Proposal on the Election of the Board of Directors and Nomination of Independent Director Candidates for the 6th Board of Directors." After review by the Nomination Committee of the Board of Directors, the Board of Directors nominated Mr. Wang Tingchun, Ms. Ou Xiuqing, and Ms. Song Yuxia as candidates for non-independent directors of the 6th Board of Directors, and nominated Mr. Li Huayi, Mr. Xie Kang, and Mr. Zhang Ronghua as candidates for independent directors of the 6th Board of Directors (the resumes of the above candidates are attached).
After the above director candidates are elected by the Company's shareholders' meeting, they will, together with the employee representative directors elected by the Company's employee representative assembly, form the 6th Board of Directors of the Company. The number of candidates for directors of the 6th Board of Directors who concurrently serve as senior management personnel of the Company and the number of directors who are employee representatives do not exceed one-half of the total number of directors of the Company. The candidates for independent directors do not have a tenure of more than six years as independent directors, and the proportion of independent director candidates is not less than one-third of the total number of directors, which meets the requirements of relevant laws and regulations. In addition, the candidates for independent directors must be submitted to the shareholders' meeting for deliberation after being reviewed and approved by the Shenzhen Stock Exchange.
To ensure the normal operation of the Board of Directors, before the new Board of Directors is established, the original directors will continue to perform their duties as directors in accordance with laws, regulations, normative documents, and the "Articles of Association."
II. Resignation of Directors
- Resignation of Independent Directors
Mr. Chen Qing, an independent director of the Company, has served as an independent director since July 28, 2020. In accordance with the relevant provisions of the "Management Measures for Independent Directors of Listed Companies," the cumulative tenure of independent directors shall not exceed six years. After the independent directors of the new Board of Directors take office, Mr. Chen Qing will no longer serve as an independent director of the Company and will not hold any position in the Company after his resignation. As of the date of this announcement, Mr. Chen Qing does not directly or indirectly hold shares in the Company and has no outstanding commitments that need to be fulfilled.
- Resignation of Non-Independent Directors